文献速递消化道肿瘤与早癌消化内镜

腺瘤检出率与临床特征影响结直肠息肉切除术后进展期肿瘤风险

Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-10-19

基于美国退伍军人事务部2004至2016年回顾性队列,30,897例基线息肉切除并后续监测结肠镜者按2:1随机分为训练集与验证集。年龄增长、男性、糖尿病、当前吸烟、腺瘤数目、息肉位置、腺瘤≥10 mm或伴绒毛状/管状绒毛状特征及结肠镜医师腺瘤检出率(ADR)降低与异时性进展期肿瘤(MAN)独立相关。结合临床因素与ADR的风险分层模型在验证集中敏感性和特异性优于2020年美国多学会结直肠癌工作组(USMSTF)监测建议(P = .001),曲线下面积0.62(95%CI 0.60-0.64)。

要点

  • 结肠镜医师ADR降低与MAN风险升高独立相关。
  • 结合临床因素与ADR的模型在验证集中优于2020 USMSTF风险分层。
  • 提高ADR可能改善息肉切除术后结局。

核心结论

  • 结肠镜医师ADR与MAN相关,结合临床因素与ADR进行风险分层有潜力改善息肉切除术后风险分层。
  • 提高ADR可能改善息肉切除术后结局。

研究设计与样本

  • 回顾性队列研究,纳入2004至2016年美国退伍军人事务部(VA)基线息肉切除并后续监测结肠镜的个体。
  • 共30,897例个体按2:1随机分配至独立的模型训练集与验证集。
  • 模型考虑临床因素、息肉发现及基线结肠镜医师ADR。
  • 模型性能(敏感性、特异性、曲线下面积)与2020年美国多学会结直肠癌工作组(USMSTF)监测建议比较。

主要发现

  • 年龄增长、男性、糖尿病、当前吸烟、腺瘤数目、息肉位置、腺瘤≥10 mm或伴管状绒毛状/绒毛状特征及结肠镜医师ADR降低与MAN独立相关。
  • ADR最低3个五分位组(ADR <19.7%-39.3%) vs 最高五分位组(ADR >47.0%),MAN风险增加1.48至1.66倍。
  • 最终模型在验证集中较2020 USMSTF风险分层获得改善的敏感性和特异性(P = .001),曲线下面积为0.62(95%CI 0.60-0.64)。

关键数值与推荐

  • ADR最低3个五分位组(ADR <19.7%-39.3%) vs 最高五分位组(ADR >47.0%),MAN风险增加1.48至1.66倍。
  • 最终模型在验证集中曲线下面积为0.62(95%CI 0.60-0.64)。
  • 最终模型在验证集中敏感性和特异性优于2020 USMSTF风险分层(P = .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Postpolypectomy risk stratification for subsequent metachronous advanced neoplasia (MAN) is imprecise and does not account for colonoscopist adenoma detection rate (ADR). Our aim was to assess association of ADR with MAN and create a prediction model for postpolypectomy risk stratification incorporating ADR and other factors. METHODS: We conducted a retrospective cohort study of individuals with baseline polypectomy and subsequent surveillance colonoscopy from 2004 to 2016 within the U.S. Department of Veterans Affairs (VA). Clinical factors, polyp findings, and baseline colonoscopist ADR were considered for the model. Model performance (sensitivity, specificity, and area under the curve) for identifying individuals with MAN was compared with 2020 U.S. Multi-Society Task Force on Colorectal Cancer (USMSTF) surveillance recommendations. RESULTS: A total of 30,897 individuals were randomly assigned 2:1 into independent model training and validation sets. Increasing age, male sex, diabetes, current smoking, adenoma number, polyp location, adenoma ≥10 mm or with tubulovillous/villous features, and decreasing colonoscopist ADR were independently associated with MAN. A range of 1.48- to 1.66-fold increased risk for MAN was observed for ADR in the lowest 3 quintiles (ADR <19.7%-39.3%) vs the highest quintile (ADR >47.0%). When the final model selected based on the training set was applied to the validation set, improved sensitivity and specificity over 2020 USMSTF risk stratification were achieved (P = .001), with an area under the curve of 0.62 (95% confidence interval, 0.60-0.64). CONCLUSIONS: Colonoscopist ADR is associated with MAN. Combining clinical factors and ADR for risk stratification has potential to improve postpolypectomy risk stratification. Improving ADR is likely to improve postpolypectomy outcomes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Gupta S, Earles A, Bustamante R, et al. Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clin Gastroenterol Hepatol. 2022. PMID: 36270618. doi:10.1016/j.cgh.2022.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。